Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
42.16
+1.25 (3.06%)
At close: Nov 11, 2026, 4:00 PM EST
42.61
+0.45 (1.06%)
Pre-market: Nov 12, 2026, 7:15 AM EST
Medline Revenue
Medline had revenue of $7.86B in the quarter ending September 26, 2026, with 10.41% growth. This brings the company's total for the last twelve months to $30.68B, up 11.85% year-over-year. In the year 2025, Medline had annual revenue of $28.43B with 11.47% growth. That makes Medline the 456th largest company in the world by revenue and 163rd in the United States.
Revenue (ttm)
$30.68B
Revenue Growth
+11.85%
P/S Ratio
1.81
Revenue / Employee
$681,778
Employees
45,000
Market Cap
55.45B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Medline breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.43B | 2.93B | 11.47% |
| Dec 31, 2024 | 25.51B | 2.28B | 9.80% |
| Dec 31, 2023 | 23.23B | 1.78B | 8.31% |
| Dec 31, 2022 | 21.45B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
MDLN News
- 1 day ago - MDLN Securities Notice: Medline Investors that Suffered Losses when Stock Plummeted 13% are Notified to Contact BFA Law about its Securities Fraud Investigation - GlobeNewsWire
- 6 days ago - Medline price target raised to $49 from $43 at UBS - TheFly
- 6 days ago - Medline price target raised to $44 from $38 at Evercore ISI - TheFly
- 7 days ago - Medline price target raised to $44 from $42 at Baird - TheFly
- 7 days ago - Medline price target raised to $47 from $45 at Citi - TheFly
- 7 days ago - Medline Earnings Call Transcript: Q3 2026 - Transcripts
- 7 days ago - Medline Earnings release: Q3 2026 - Filings
- 7 days ago - Medline Slides: Q3 2026 - Filings